Home

White Paper

The Path to CAR T–Cell Therapy

The Path to CAR T–Cell Therapy

IQVIA
Pages 19 Pages

Based on survey data across the referral-to-treatment pathway, this paper identifies key barriers preventing eligible patients from receiving CAR T-cell therapy. It highlights challenges at both referring centers and authorized treatment centers, including eligibility perceptions, logistics, affordability, and operational complexity. The paper proposes targeted solutions for clinicians, administrators, patient advocacy groups, and manufacturers to reduce drop-off and expand access.

Join for free to read

You Might Also Like


Pathways to Overcome Challenges to CAR T-cell Therapy Readiness
Ebook Pathways to Overcome Challenges to CAR T-cell Therapy Readiness
IQVIA

Achieving CAR T-cell Therapy Health System Readiness
Report Achieving CAR T-cell Therapy Health System Readiness
IQVIA

Building a CAR-T Toolbox for More Comprehensive Assessment of Cell Therapies
Case Study Building a CAR-T Toolbox for More Comprehensive Assessment of…
Agilent

Safety, Efficacy, Cost: The Trifecta for Increasing Access to CAR-T Therapies
White Paper Safety, Efficacy, Cost: The Trifecta for Increasing Access to…
Premier Research

More from IQVIA


Pathways to Overcome Challenges to CAR T-cell Therapy Readiness
Ebook Pathways to Overcome Challenges to CAR T-cell Therapy Readiness
IQVIA

Achieving CAR T-cell Therapy Health System Readiness
Report Achieving CAR T-cell Therapy Health System Readiness
IQVIA

Designing and Delivering Cell and Gene Therapy Clinical Trials: A strategic approach to CAGT study conduct and operations
Ebook Designing and Delivering Cell and Gene Therapy Clinical Trials:…
IQVIA

Evolving Landscape of Immuno-Oncology
White Paper Evolving Landscape of Immuno-Oncology
IQVIA
© 2026 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info